News
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback